Genome Editing Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Genome Editing Market is segmented By Type of Gene Editing Technique (CRISPR-Cas System, TALENs, Meganucleases, ZFNs, Other Techniques), By Type of Therapy (Cell Therapies, Gene Therapies, Other Therapies), By Gene Editing Approach (Gene Knock-Out Approaches, Gene Knock-In Approaches), By Gene Delivery Method(Ex-Vivo Delivery Methods, In-Vivo Delivery Methods), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.

Genome Editing Market Size

Market Size in USD

CAGR12.6%

Study Period2024 - 2031
Base Year of Estimation2023
CAGR12.6%
Market ConcentrationMedium
Major PlayersCRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Beam Therapeutics, Caribou Biosciences
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
setting-icon
Want to purchase customized report?
please let us know !

Genome Editing Market Analysis

The genome editing market is estimated to be valued at USD 3.90 Bn in 2024 and is expected to reach USD 8.95 Bn by 2031, growing at a compound annual growth rate (CAGR) of 12.6% from 2024 to 2031. The increasing prevalence of genetic disorders and cancer along with advancement in genome editing technologies is driving the growth of genome editing market.